387 related articles for article (PubMed ID: 28831992)
1. Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis.
Jinatongthai P; Kongwatcharapong J; Foo CY; Phrommintikul A; Nathisuwan S; Thakkinstian A; Reid CM; Chaiyakunapruk N
Lancet; 2017 Aug; 390(10096):747-759. PubMed ID: 28831992
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review.
Dundar Y; Hill R; Dickson R; Walley T
QJM; 2003 Feb; 96(2):103-13. PubMed ID: 12589008
[TBL] [Abstract][Full Text] [Related]
3. Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis.
Li HY; Wang YB; Ren XY; Wang J; Wang HS; Jin YH
Pharmacology; 2023; 108(2):111-126. PubMed ID: 36603558
[TBL] [Abstract][Full Text] [Related]
4. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
6. The outcomes of reperfusion therapy with streptokinase versus tenecteplase in ST-elevation myocardial infarction (STEMI): a propensity-matched retrospective analysis in an Asian population.
Koh HP; Md Redzuan A; Mohd Saffian S; Nagarajah JR; Ross NT; Hassan H
Int J Clin Pharm; 2022 Jun; 44(3):641-650. PubMed ID: 35243572
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic agents for the management of ST-segment elevation myocardial infarction.
Hilleman DE; Tsikouris JP; Seals AA; Marmur JD
Pharmacotherapy; 2007 Nov; 27(11):1558-70. PubMed ID: 17963464
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of randomized clinical trials comparing bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarction.
Nairooz R; Sardar P; Amin H; Swaminathan RV; Kim LK; Chatterjee S; Feldman DN
Am J Cardiol; 2014 Jul; 114(2):250-9. PubMed ID: 24890986
[TBL] [Abstract][Full Text] [Related]
9. Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysis.
Giraldez RR; Wiviott SD; Nicolau JC; Mohanavelu S; Morrow DA; Antman EM; Giugliano RP
Drugs; 2009 Jul; 69(11):1433-43. PubMed ID: 19634922
[TBL] [Abstract][Full Text] [Related]
10. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
Topol EJ;
Lancet; 2001 Jun; 357(9272):1905-14. PubMed ID: 11425410
[TBL] [Abstract][Full Text] [Related]
11. [Comparative effect of streptokinase and alteplase on electrocardiogram and angiogram signs of myocardial reperfusion in ST segment elevation acute myocardial infarction].
Tomasević M; Kostić T; Apostolović S; Perisić Z; Djordjević-Radojković D; Koraćević G; Salinger-Martinović S
Srp Arh Celok Lek; 2008; 136(9-10):481-7. PubMed ID: 19069338
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) versus alteplase (rt-PA) as fibrinolytic therapy for acute ST-segment elevation myocardial infarction (China TNK STEMI): protocol for a randomised, controlled, non-inferiority trial.
Wang HB; Ji P; Zhao XS; Xu H; Yan XY; Yang Q; Yao C; Gao RL; Wu YF; Qiao SB
BMJ Open; 2017 Sep; 7(9):e016838. PubMed ID: 28928186
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.
French JK; Edmond JJ; Gao W; White HD; Eikelboom JW
Am J Cardiovasc Drugs; 2004; 4(2):107-15. PubMed ID: 15049722
[TBL] [Abstract][Full Text] [Related]
14. Tenecteplase: a review of its pharmacology and therapeutic efficacy in patients with acute myocardial infarction.
Dunn CJ; Goa KL
Am J Cardiovasc Drugs; 2001; 1(1):51-66. PubMed ID: 14728052
[TBL] [Abstract][Full Text] [Related]
15. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction.
Martínez-Ríos MA; Rosas M; González H; Peña-Duque MA; Martínez-Sánchez C; Gaspar J; García H; Gaxiola E; Delgado L; Carrillo J; Leyva JL; Lupi E;
Am J Cardiol; 2004 Feb; 93(3):280-7. PubMed ID: 14759375
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
[TBL] [Abstract][Full Text] [Related]
17. Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: comparison of prehospital tirofiban versus fibrinolysis before direct PCI.
Möckel M; Bocksch W; Strohm S; Kühnle Y; Vollert J; Nibbe L; Dietz R
Int J Cardiol; 2005 Aug; 103(2):193-200. PubMed ID: 16080980
[TBL] [Abstract][Full Text] [Related]
18. Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
De Luca G; Marino P
Am J Emerg Med; 2009 Jul; 27(6):683-90. PubMed ID: 19751625
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials.
De Luca G; Marino P
Am Heart J; 2007 Dec; 154(6):1085.e1-6. PubMed ID: 18035079
[TBL] [Abstract][Full Text] [Related]
20. Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction.
Roe MT; Green CL; Giugliano RP; Gibson CM; Baran K; Greenberg M; Palmeri ST; Crater S; Trollinger K; Hannan K; Harrington RA; Krucoff MW;
J Am Coll Cardiol; 2004 Feb; 43(4):549-56. PubMed ID: 14975462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
